A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. This unique biomarker can be detected in the urine samples of patients with prostate cancer, offering a non-invasive means of detection.
Currently, the prostate specific antigen (PSA) exam is used as the standard screening method for prostate cancer. However, elevated PSA levels are not exclusive to prostate cancer, as they can also be caused by benign prostate conditions. As a result, an elevated PSA test can sometimes lead to an unnecessary prostate biopsy for the patient, which carries a risk of bleeding and infection. Findings from this research may offer a more accurate and reliable method to diagnose prostate cancer.
“This study is exciting because it has the potential to offer a non-invasive alternative to the traditional PSA test in order to diagnose significant prostate cancers,” said Craig Rogers, M.D., chair of the Vattikuti Urology Institute at Henry Ford Health System. “The discovery of new biomarkers ultimately benefits our patients, as it advances our understanding of this complex disease and how to most effectively treat it.”
When the KLK4 protein coding gene and KLKP1 pseudogene fuse together, the fusion gene KLK4-KLKP1 is formed. Pseudogenes like KLKP1 are the non-functional, or dead, versions of an actual gene that is normally not expressed in a cell but can become active in cancerous cells and disrupt the functions of the actual gene.
“The unique feature of this fusion gene is the conversion of the noncoding pseudogene KLKP1 into a protein coding gene, and its unique expression in about 30 percent of high Gleason grade prostate cancer,” said Dr. Palanisamy. “Like other ETS family gene fusions, KLK4-KLKP1 can also be detected in the urine samples of patients with prostate cancer, enabling non-invasive detection of prostate cancer. Given the unique feature of this fusion, prostate cancer specific expression, oncogenic properties and noninvasive detection, this novel gene fusion has the potential to be used as a biomarker for early detection of prostate cancer and a therapeutic target.”
The researchers conducting this study screened a cohort of 659 patients (380 Caucasian American; 250 African American, and 29 patients of other races), which revealed that the KLK4-KLKP1 fusion gene is expressed in about 32 percent of prostate cancer patients, representing a distinct subset of prostate cancer cases. Correlative analysis showed that the new fusion gene can be used in combination with other prostate cancer molecular markers for cancer detection. In addition to urine samples, the fusion could also be detected in needle biopsy tissue samples by using a specific antibody.
Prostate cancer is the most common cancer among men in the United States. Advances in diagnosis, treatment, and management have resulted in increased survival rates, yet prostate cancer still remains the second leading cause of cancer-related deaths among American men. One of the major barriers to achieving successful prostate cancer control is the underlying molecular complexity of the disease itself.
The Latest on: Prostate cancer
[google_news title=”” keyword=”prostate cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Prostate cancer
- Are Younger People At Risk Of Prostate Cancer?on February 22, 2024 at 10:51 pm
Prostate cancer is one of the most common cancers in older men. We asked an expert whether younger people could develop it too.
- Exercise programme at Ibrox helping men with prostate cancer ‘look forward’on February 22, 2024 at 5:00 pm
A free exercise programme at Ibrox Stadium is helping men with prostate cancer ‘look forward’ again. Prostate Scotland and the SPFL Trust have launched Prostate FFIT - a 12-week initiative designed to ...
- Impact of Hormone Therapy on Cognition in Prostate Cancer Still Unclearon February 21, 2024 at 4:00 pm
Researchers found “no conclusive evidence of a decline in objective cognition” in patients with prostate cancer receiving hormone therapy. There is no consensus on how hormone therapy impacts ...
- Perceived vs Actual Cognitive Impairment in Prostate Canceron February 21, 2024 at 4:00 pm
Patients with prostate cancer receiving hormone therapy reported greater perceived cognitive difficulties, but cognitive tests found "no conclusive evidence of a decline," a new meta-analysis found.
- What Is The Life Expectancy Of Prostate Cancer? A Review By Doctorson February 21, 2024 at 1:28 pm
Expert opinion from Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA The prognosis for someone with prostate cancer depends primarily on the results ...
- Is MRI Screening Unnecessarily High in Prostate Cancer?on February 21, 2024 at 3:53 am
New research suggests that review of current prostate cancer screening guidelines may be needed, as MRI frequently fails to detect cancer-indicative lesions, even in men with elevated PSA levels.
- Prostate cancer is a silent killer, but early detection saves lives | Opinionon February 20, 2024 at 6:32 am
Prostate cancer is the second most common cancer among men after skin cancer, as reported by the Centers for Disease Control and Prevention.
- Black Men With Advanced Prostate Cancer Are Less Likely to Get the Most Effective Therapieson February 19, 2024 at 4:00 pm
Learn about disparities in the use of second-generation androgen receptor inhibitors for prostate cancer and how to improve outcomes.
- An Expert Explains Why Black Men Are at a Greater Risk for Prostate Canceron February 14, 2024 at 6:54 am
In the United States, Black men have the highest incidence and mortality rates from prostate cancer than any other ethnic group. Specifically, the incidence and mortality rates of prostate cancer ...
- Can Exercise Help Prevent Prostate Cancer?on February 12, 2024 at 7:58 am
A new study adds to growing evidence that exercise is an important part of preventing one of America’s deadliest cancers.
via Bing News